Pear Therapeutics (PEAR) PT Lowered to $7 at Credit Suisse
Tweet
Share
E-mailGet Alerts PEAR Hot Sheet
Price: $0.03 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Credit Suisse analyst Judah Frommer lowered the price target on Pear Therapeutics (NASDAQ: PEAR) to $7.00 (from $9.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Destination XL Group (DXLG) PT Lowered to $1.25 at DA Davidson on Weak Consumer Spending
- Clear Secure Inc (YOU) PT Lowered to $45 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
